Wearable Robotics Closes $5.5M Series A to Scale Development

Why It Matters

The infusion of $5.5 million positions Wearable Robotics to scale cutting‑edge rehab technology globally, potentially reshaping post‑stroke and injury recovery markets.

Key Takeaways

• Raised €5M (~$5.5M) Series A funding.
• Expanding modular wearable robotics for rehab worldwide.
• ALEX RS already deployed in 50+ international sites.
• Targeting North American market and regulatory approvals.
• Scaling commercial network with new partnerships.

Pulse Analysis

The rehabilitation technology sector is experiencing a surge of investment as clinicians seek data‑driven, patient‑centric solutions. Wearable Robotics' recent €5 million Series A reflects investor confidence in the convergence of robotics, augmented reality, and virtual reality for neuromotor recovery. By securing backing from CDP Venture Capital and a consortium of Italian tech investors, the company joins a wave of European startups leveraging public‑private funds to accelerate commercialization and compete with U.S. incumbents.

At the core of Wearable Robotics' strategy is its ALEX RS system, a bilateral upper‑limb platform already installed in over 50 clinics across Europe, the Middle East, and Asia. The device combines sensor‑rich exoskeletons with immersive AR/VR environments, delivering quantified therapy sessions that clinicians can monitor in real time. Building on this foundation, the firm plans to roll out modular, integrable units that address additional joints and functional tasks, shortening development cycles and simplifying regulatory pathways. Early engagement with European medical device authorities aims to secure CE marking, while parallel efforts target FDA clearance for the U.S. market.

The funding round also earmarks resources for expanding the company’s commercial footprint, particularly in North America where demand for home‑based and outpatient rehabilitation solutions is rising sharply. Strategic partnerships with distributors and health‑system providers will enable rapid market entry and scale. As insurers increasingly reimburse technology‑enabled therapy, Wearable Robotics is poised to capture a sizable share of a market projected to exceed $10 billion by 2030, reinforcing Europe’s emerging role as a hub for advanced medical robotics.

Deal Summary

Wearable Robotics, an Italy-based developer of wearable robotics for neuromotor rehabilitation, raised $5.5 million in a Series A round led by CDP Venture Capital, with participation from MITO Technology, LIFTT, SIMEST, RoboIT and Toscana Next. The funding will support international expansion, product development, regulatory approvals and scaling of commercial operations.